Leading global supplier of drug delivery devices fully integrates acquired company to have one version of the truth
Feltham, UK — SAP UK & Ireland today announced that Bespak, a leading supplier of drug delivery devices for injectable and inhaled products has integrated acquired organisation Bespak Injectables (formerly The Medical House) onto SAP Business All-in-One. Headquarted in the UK, Bespak employs over 500 people and manufactures more than 600 million medical devices each year. Bespak provides the capability and expertise to reduce time to market, allowing customers’ products to be developed, tested and manufactured faster and with minimised risk, whilst complying with the EEC Medical Device Directive and the US Food and Drug Administration (FDA).
Bespak has been an SAP customer since 1998 with the system supporting the administrative, manufacturing and distribution functions. In November 2009, Consort Medical PLC acquired The Medical House PLC and began the integration of the re-branded Bespak Injectables into its Bespak division. In order to drive further efficiencies out of its existing SAP investment and to integrate Bespak Injectables’ data to provide administrative synergies, Bespak began moving the company from its existing IT systems onto SAP Business All-in-One.
“Ensuring we have accurate, timely information across the business is imperative to Bespak as we are dealing with critical medical products which need to comply with stringent FDA regulations,” commented Mark Newman, SAP Service Manager at Bespak.
Bespak identified the opportunity to expand the use of its well established SAP system and made the decision to integrate Bespak Injectables’ systems with Bespak’s so began the search for a systems integrator.
Newman continued “We selected Chelford because of their knowledge of the system, the strong references they had, the fact that they were highly regarded by SAP and that they also understood fully what we were trying to achieve and wanted to work with us as a team to ensure we would get the results we wanted.”
“The implementation was relatively straightforward because we were moving Bespak Injectables over to an existing SAP solution. The integration was rapid and took only 60 days from start to finish. We are pleased that the integration means that there are huge benefits Bespak will realize; they now have a robust platform for growth and better financial reporting with faster closing for month end with more accurate information,” said John Brennan, Chelford Group.
Stephen Read, Director of SME, SAP UK & Ireland commented; “This is yet another successful implementation with our valued partner Chelford. Their understanding of our solutions and dedication ensures that we have successful implementations and happy customers. I am delighted that Bespak has chosen to invest further into SAP Business All-in-One and I look forward to continuing our relationship moving into the future.”
SAP is the world’s leading provider of business software(*), offering applications and services that enable companies of all sizes and in more than 25 industries to become best-run businesses. With more than 105,000 customers in over 120 countries, the company is listed on several exchanges, including the Frankfurt stock exchange and NYSE, under the symbol “SAP.” For more information, visit www.sap.com.
(*) SAP defines business software as comprising enterprise resource planning, business intelligence, and related applications.
Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,” “project,” “predict,” “should” and “will” and similar expressions as they relate to SAP are intended to identify such forward-looking statements. SAP undertakes no obligation to publicly update or revise any forward-looking statements. All forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. The factors that could affect SAP’s future financial results are discussed more fully in SAP’s filings with the U.S. Securities and Exchange Commission (“SEC”), including SAP’s most recent Annual Report on Form 20-F filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates.
Copyright © 2010 SAP AG. All rights reserved.
SAP, R/3, mySAP, mySAP.com, xApps, xApp, SAP NetWeaver and other SAP products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of SAP AG in Germany and in several other countries all over the world. All other product and service names mentioned are the trademarks of their respective companies. Data contained in this document serve informational purposes only. National product specifications may vary.
Note to editors:
To preview and download broadcast-standard stock footage and press photos digitally, please visit www.sap.com/photos. On this platform, you can find high resolution material for your media channels. To view video stories on diverse topics, visit www.sap-tv.com. From this site, you can embed videos into your own Web pages, share video via e-mail links and subscribe to RSS feeds from SAP TV.
Follow SAP on Twitter at @sapnews.
For more information, press only:
Molly McDonagh, UKI PR Manager, SAP, email@example.com / +44 (0)7966 975 287